Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001753926-25-001075

Director acquired 1,500,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Davis Todd C Director 2025-07-01 Conversion +1,500,000 $10.00 $15,000,000 1,500,000 I
Derivatives
Davis Todd C Director 2025-07-01 Conversion · Series A Convertible Preferred Stock −15,000 3,000 I
Davis Todd C Director 2025-07-01 Other acquisition · Series A Convertible Preferred Stock +31,278.68 3,127,868 I
Loading xslF345X05/ownership.xml…